In mouse models of stroke and retinal degeneration, the inhibition of the TRPM4-interacting domain, called TwinF, by small molecular inhibitors proved to reduce excitotoxicity without impairing the function of synaptic NMDA receptors [289]. This evidence concerns the gene TRPM4 and Stroke.